XML 18 R7.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Cash flows from operating activities:    
Net loss $ (952,808) $ (4,211,006)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 210,789 220,246
Share-based compensation 450,167 515,380
Non-cash interest 18,003 491,976
Loss on the sale cryptocurrencies 80,057
Changes in operating assets and liabilities:    
Accounts receivable (1,761,635) (887,494)
Unbilled receivables (279,313) 280,617
Change in convertible note fair value (22,602)
Change in fair value of cryptocurrency (2,427,754)
Prepaid expense and other assets 124,526 195,723
Accounts payable (160,057) (292,155)
Accrued expenses (261,143) (1,138,213)
Income tax payable (80,049) (9,598)
Net cash used in operating activities (5,039,217) (4,857,126)
Cash flows from investing activities:    
Purchase of cryptocurrencies (2,748,777)
Sale of cryptocurrencies 1,920,064
Capitalization of software development costs (156,118) (171,997)
Purchase of property and equipment (1,882)
Net cash used in investing activities (984,831) (173,879)
Cash flows from financing activities:    
Proceeds from notes payable, net of discounts 2,000,000 873,000
Repayment of insurance financing payable (70,489) (100,464)
Repayment of short-term borrowings (6,103,131) (8,150,791)
Proceeds from short-term borrowings 7,611,183 9,848,259
Proceeds from the issuance of Series A4 Shares 2,970,000
Net proceeds from the issuance of Ordinary Shares 1,453,589
Net cash provided by financing activities 6,407,563 3,923,593
Net increase (decrease) in cash and cash equivalents 383,515 (1,107,412)
Effect of exchange rate changes on cash and cash equivalents (889) 7,883
Cash and cash equivalents at beginning of the period 204,032 1,560,105
Total cash, cash equivalents and restricted cash shown in the consolidated statement of cash flows 586,658 460,576
Supplemental disclosure of cash flow information    
Cash paid for interest 325,109 675,628
Supplemental disclosure of non-cash activity    
Financing of insurance premiums 180,411 222,891
Reconciliation of cash, cash equivalents, and restricted cash reported in the consolidated balance sheet    
Cash and cash equivalents $ 586,658 $ 460,576